169 results on '"BOHN, MARTHA"'
Search Results
2. Mesenchymal stem cells and neuroregeneration in Parkinson's disease
3. Gene Therapies for Parkinson’s Disease
4. Cryoballoon versus Radiofrequency Catheter Ablation for Paroxysmal Atrial Fibrillation
5. Adrenal Medulla Grafts Enhance Recovery of Striatal Dopaminergic Fibers
6. Hypothalamic IGF-I Gene Therapy Prolongs Estrous Cyclicity and Protects Ovarian Structure in Middle-Aged Female Rats
7. Inclusion of a portion of the native SNCA 3′UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia Nigra
8. Gene Transfer for Neuroprotection in Animal Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis
9. Regulation of Substance P Expression and Metabolismin vivoandin vitro
10. Transmitter Phenotypic Expression in the Embryo
11. Protocol-driven prevention of perioperative hypothermia in the pediatric neurosurgical population
12. Applications of Gene Therapy to Neurological Diseases and Injuries
13. Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi
14. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo
15. Maternal Glucocorticoid Hormones Influence Neurotransmitter Phenotypic Expression in Embryos
16. Motoneurons crave glial cell line-derived neurotrophic factor
17. Experiments in a Parkinson's Rat Model
18. Evidence - in a case of a grandfather's sexual abuse of his one--month-old granddaughter, trial court did not err in admitting evidence of defendant's sexual contacts with his stepdaughter at age four to prove absence of mistake and defendant's identity. In addition, prison sentence of between fifteen and fifty years was not too severe.
19. In Vitro Approaches to Studying Glucocorticoid Effects on Gene Expression in Neurons and Glia
20. Contributors to Volume 22
21. The Ontogeny of Adrenergic Fibers in Rat Spinal Cord
22. The Ontogeny of Adrenergic Fibers in Rat Spinal Cord
23. Transmitter Phenotypic Plasticity In Developing and Mature Neurons in Vivo
24. Reconnection Rate and Long-Term Outcome with Adenosine Provocation During Cryoballoon Ablation for Pulmonary Vein Isolation
25. Moderate Sedation Reduces Lab Time Compared to General Anesthesia during Cryoballoon Ablation for AF Without Compromising Safety or Long-Term Efficacy
26. Contracts concerning abortion
27. Substance P in Principal Sympathetic Neurons: Regulation by Impulse Activity
28. Corticospinal Motor Neurons Are Susceptible to Increased ER Stress and Display Profound Degeneration in the Absence of UCHL1 Function
29. Chapter 69 Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla
30. Gene Therapies for Parkinson's Disease
31. Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects
32. Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies
33. POST-PROCEDURAL DABIGATRAN VERSUS STANDARD ANTICOAGULATION IN ABLATION FOR ATRIAL FIBRILLATION
34. AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS
35. An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
36. A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons
37. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
38. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury
39. Novel Magnetic Hydroxyapatite Nanoparticles as Non‐Viral Vectors for the Glial Cell Line‐Derived Neurotrophic Factor Gene
40. Reversal of Dopaminergic Degeneration in a Parkinsonian Rat following Micrografting of Human Bone Marrow-Derived Neural Progenitors
41. Non-Viral Delivery of the Gene for Glial Cell Line-Derived Neurotrophic Factor to Mesenchymal Stem Cells In Vitro Via a Collagen Scaffold
42. Progressive degeneration of dopamine neurons in 6‐hydroxydopamine rat model of parkinson's disease does not involve activation of caspase‐9 and caspase‐3
43. The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the Brain
44. Glial Cell Line-Derived Neurotrophic Factor (GDNF) Gene Delivery Protects Dopaminergic Terminals from Degeneration
45. Quantitative Analysis of Transgene Protein, mRNA, and Vector DNA Following Injection of an Adenoviral Vector Harboring Glial Cell Line-Derived Neurotrophic Factor into the Primate Caudate Nucleus
46. Delivery of a GDNF Gene into the Substantia Nigra after a Progressive 6-OHDA Lesion Maintains Functional Nigrostriatal Connections
47. Glial cell line‐derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of Antonia Vernadakis on neuronal–glial interactions
48. Parkinson's Disease: A Neurodegenerative Disease Particularly Amenable to Gene Therapy
49. Intramuscular Grafts of Myoblasts Genetically Modified to Secrete Glial Cell Line-Derived Neurotrophic Factor Prevent Motoneuron Loss and Disease Progression in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
50. Adenovirus-Mediated Transgene Expression in Nonhuman Primate Brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.